Who owns LONGBOARD PHARMACEUTICALS IN?
- Ticker: LBPH
- CUSIP Number: 54300n103
Tip: Access positions for across all investors
Analyze quarterly positions in Longboard Pharmaceuticals In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Longboard Pharmaceuticals In stock
Who bought or sold LONGBOARD PHARMACEUTICALS IN this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Cormorant Asset Management | 2.4M | $14M | 0% | Dec 2023 |
|
T. Rowe Price Associates | 1.6M | $9.8M | -8% | Dec 2023 |
|
Ikarian Capital | 980k | $5.9M | 91% | Dec 2023 |
|
Point72 Asset Management | 825k | $5.0M | 0% | Dec 2023 |
|
Vanguard Group | 786k | $4.7M | 1% | Dec 2023 |
|
Jpmorgan Chase & Co | 535k | $3.2M | 0% | Dec 2023 |
|
Jennison Associates | 481k | $2.9M | 100% | Dec 2023 |
|
TD Asset Management | 94k | $567k | -23% | Dec 2023 |
|
Schonfeld Strategic Advisors | 92k | $557k | 10% | Dec 2023 |
|
Bank of New York Mellon | 69k | $1.5M | 51% | Mar 2024 |
|
Charles Schwab Investment Management | 43k | $259k | 0% | Dec 2023 |
|
Walleye Trading Advisors | 39k | $237k | 100% | Dec 2023 |
|
Dimensional Fund Advisors | 33k | $198k | 164% | Dec 2023 |
|
Jacobs Levy Equity Management | 24k | $144k | 100% | Dec 2023 |
|
Laurion Capital Management | 22k | $132k | -17% | Dec 2023 |
|
Barclays | 21k | $129k | 669% | Dec 2023 |
|
Bank of America Corporation | 19k | $112k | 44% | Dec 2023 |
|
Rhumbline Advisers | 16k | $98k | 0% | Dec 2023 |
|
UBS Group | 15k | $92k | 84% | Dec 2023 |
|
Goldman Sachs Group | 14k | $83k | 24% | Dec 2023 |
|
New York State Common Retirement Fund | 12k | $73k | 0% | Dec 2023 |
|
Denali Advisors | 9.3k | $201k | 100% | Mar 2024 |
|
American International | 7.7k | $47k | 0% | Dec 2023 |
|
Royal Bank of Canada | 5.2k | $31k | 94% | Dec 2023 |
|
Wells Fargo & Company | 4.5k | $27k | 26% | Dec 2023 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 3.2k | $19k | 0% | Dec 2023 |
|
Citigroup | 2.3k | $14k | 32071% | Dec 2023 |
|
Simplex Trading | 1.7k | $36k | 100% | Mar 2024 |
|
Legal & General Group | 1.7k | $10k | 0% | Dec 2023 |
|
Summit Investment Advisors | 1.3k | $7.8k | 0% | Dec 2023 |
|
Amalgamated Bank | 841.00 | $18k | -49% | Mar 2024 |
|
ADAR1 Capital Management | 800.00 | $4.8k | 100% | Dec 2023 |
|
LifeSteps Financial | 200.00 | $4.3k | 100% | Mar 2024 |
|
GAMMA Investing | 72.00 | $1.6k | 100% | Mar 2024 |
|
Who sold out of Longboard Pharmaceuticals In?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Moore Capital Management | Sep 2023 | 46k | $254k |
Millennium Management | Sep 2023 | 17k | $95k |
Bourgeon Capital Management | Dec 2023 | 7.0k | $42k |